News
Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss: Study
Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...
Combing a weight-loss drug and hormone therapy may be the key to shedding pounds.
Preclinical study shows oral PL7737 agonist outperforms tirzepatide alone in rodent models, supporting Palatin’s plans for ...
Discover how Semaglutide helped me lose 120 pounds and transform my life. A personal, honest look at the ups, downs, and what really worked.
For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss.
Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...
The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health ...
A drag artist from Swansea has undergone a remarkable transformation, losing 14 stone with the help of the weight-loss ...
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
Presented by AstraZeneca{beacon} Health Care Health Care The Big Story CMS targets hospitals with site-neutral drug ruleThe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results